Our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. With our broad portfolio of marketed and development-stage respiratory products we’re making good progress towards achieving our goal.
http://www.circassia.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
6.6 seconds
16x16
32x32
Whois Privacy Services Pty Ltd
Domain Hostmaster, Customer ID : 83520254688136
PO ●●●923
Forti●●●●●alley , QLD, 4006
AUSTRALIA
View this contact
Whois Privacy Services Pty Ltd
Domain Hostmaster, Customer ID : 83520254688136
PO ●●●923
Forti●●●●●alley , QLD, 4006
AUSTRALIA
View this contact
Whois Privacy Services Pty Ltd
Domain Hostmaster, Customer ID : 83520254688136
PO ●●●923
Forti●●●●●alley , QLD, 4006
AUSTRALIA
View this contact
BUY YOUR DOMAIN
23
YEARS
10
MONTHS
10
DAYS
FABULOUS.COM PTY LTD.
WHOIS : whois.fabulous.com
REFERRED : http://www.fabulous.com
PAGES IN
THIS WEBSITE
19
SSL
EXTERNAL LINKS
16
SITE IP
83.223.123.87
LOAD TIME
6.572 sec
SCORE
6.2
A world-class specialty pharmaceutical company – Circassia | circassia.com Reviews
https://circassia.com
Our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. With our broad portfolio of marketed and development-stage respiratory products we’re making good progress towards achieving our goal.
circassia.com
Warning to shareholders – Circassia
http://www.circassia.com/investors/warning-to-shareholders
Skip to main content. Our ToleroMune technology identifies unique combinations of synthetic peptides to treat allergies with a short-course of therapy. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. House dust mite allergy. Flixotide / Flovent substitute.
Share price summary – Circassia
http://www.circassia.com/investors/trade-table
Skip to main content. Our ToleroMune technology identifies unique combinations of synthetic peptides to treat allergies with a short-course of therapy. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. House dust mite allergy. Flixotide / Flovent substitute.
Financial reports – Circassia
http://www.circassia.com/investors/financial-reports
Skip to main content. Our ToleroMune technology identifies unique combinations of synthetic peptides to treat allergies with a short-course of therapy. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. House dust mite allergy. Flixotide / Flovent substitute.
Grass allergy – Pipeline Product – Circassia
http://www.circassia.com/portfolio/grass
Skip to main content. Our ToleroMune technology identifies unique combinations of synthetic peptides to treat allergies with a short-course of therapy. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. House dust mite allergy. Flixotide / Flovent substitute.
Regulatory news – Circassia
http://www.circassia.com/investors/regulatory-news
Skip to main content. Our ToleroMune technology identifies unique combinations of synthetic peptides to treat allergies with a short-course of therapy. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. House dust mite allergy. Flixotide / Flovent substitute.
TOTAL PAGES IN THIS WEBSITE
19
Prosonix - Home
http://prosonix.co.uk/home
On 15 June 2015, Prosonix was acquired by Circassia Pharmaceuticals plc creating a world-class allergy and asthma specialty biopharma business . For more information on Circassia, please go to www.circassia.com. May 15, 2015. Prosonix enters Definitive Agreement to be acquired by Circassia Pharmaceuticals plc for up to 100 million in Cash. Sep 11, 2014. Prosonix Confirms the Potential of its Multi-Component Particle Technology for Developing Novel Inhaled Dual. Sep 2, 2014. Prosonix Ltd, 2016.
Mittelteil Allergie-News werbefrei
http://www.presseinformationen.info/mittelteil_presseinfos_pharmaunternehmen_ssi.html
010916, Uhrzeit: 03.25 ssi. Für die Öffentlichkeit bestimmte Informationen der Pharma- und Medizingeräte-industrie sind generell als Werbung zu werten. Weiter legal möglich (Stand der Rechtslage Juni 2016). Ein zweites deutsches Verwaltungsgericht (Köln). Doch sobald diese für die Produktion von injizierbaren Thymus-Peptiden erforderlichen Wirkstoffe von einem Anbieter bezogen werden , der - wie das Pharmaunternehmen. Sanorell Pharma Mai 2016. Volltext Originalurteil des Verwaltungsgerichts Köln hier.
Knowledge in Every Breath - Aerocrine
http://www.aerocrine.com/en
Watch the NIOX VERO Video Presentation. Learn more about Circassia by following this link. Solving the asthma patient puzzle. EAACI 11-15/6, 2016 Vienna, Austria. ERS 3-7/9, 2016 London, UK. FeNO: A valuable biomarker for Asthma Phenotyping. Learn from the experts at a Practical Workshop, ERS in London. EU funded project supporting asthma patients to control their disease through mHealth. See the latest Newsletter.
Diagnosis and control of airways disease - Aerocrine
http://www.aerocrine.com/en/About-Aerocrine
Aerocrine at a glance. Aerocrine is a medical technology company focused on improving the treatment of patients with inflamed airways. Measuring airways inflammation helps doctors to diagnose, monitor and optimise therapy for people with inflammatory airway diseases. Aerocrine will continue to develop products to improve the quality of life, management and care of people with airways inflammatory disease. Aerocrine is revolutionizing the way that inflammatory airways disease is managed.
Mittelteil Allergie-News werbefrei
http://www.presseerklaerungen.de/mittelteil_presseinfos_pharmaunternehmen_ssi.html
010916, Uhrzeit: 09.27 ssi. Für die Öffentlichkeit bestimmte Informationen der Pharma- und Medizingeräte-industrie sind generell als Werbung zu werten. Weiter legal möglich (Stand der Rechtslage Juni 2016). Ein zweites deutsches Verwaltungsgericht (Köln). Doch sobald diese für die Produktion von injizierbaren Thymus-Peptiden erforderlichen Wirkstoffe von einem Anbieter bezogen werden , der - wie das Pharmaunternehmen. Sanorell Pharma Mai 2016. Volltext Originalurteil des Verwaltungsgerichts Köln hier.
TOTAL LINKS TO THIS WEBSITE
16
circassia-russian.blogspot.com
Черкесское Хасэ "Содействие Родине"
Черкесское Хасэ "Содействие Родине". Вторник, 22 июля 2014 г. Международная черкесская организация поддержки репатриации начала свою работу. В июле 2014 года официально начала свою работу Международная Черкесская организации поддержки черкесских репатриантов. Официально организация называется Черкесская организация поддержки репатриации. Зарегистрирована она в Канаде, центральный офис находится в городе Ватерлоо. Пятница, 27 июня 2014 г. Суббота, 15 марта 2014 г. Среда, 8 января 2014 г. В Адыгее строится...
circassia-turkish.blogspot.com
Ana vatan için Çerkes Khase
Ana vatan için Çerkes Khase. 8 Ocak 2014 Çarşamba. Suriye'de ayaklanma başladığından bugüne yaklaşık 1600 Çerkes vatana döndü. Suriyede ayaklanma başladığından bugüne yaklaşık 1600 Çerkes vatana döndü. Bunlardan 750 kişi Kabardey-Balkar Cumhuriyetine, 30 kişi Karaşay-Çerkes Cumhuriyetine, 600 kişi de Adıgey Cumhuriyetine dönüş yaptı. 9 Aralık 2012 Pazar. SURİYE’DEN ANAVATANINA DÖNEN AİLENİN KIZI OLDU. 6 Eylül 2012 Perşembe. KAFFED yetkilileri DÇB Toplantısı İçin Nalçik'e. 27 Ağustos 2012 Pazartesi. Son a...
A world-class specialty pharmaceutical company – Circassia
Skip to main content. Our proprietary particle-engineering technologies underpin our portfolio of respiratory product candidates, and we have a number of asthma and COPD products in development. Our NIOX products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation. Flixotide / Flovent substitute. Seretide / Advair substitute. Novel LABA / LAMA formulation & novel COPD therapy formulation. Circassia is li...
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
Welcome circassia.org - Hostmonster.com
Web Hosting - courtesy of www.hostmonster.com.
Domain circassia.ru maybe for sale
Companies from Fortune 500 list. Grew out of a small business, thanks to. Domain is parked by service DomainParking.ru.
Хэкум Фэлажьэрэ Адыгэ Хасэ
Хэкум Фэлажьэрэ Адыгэ Хасэ. 22 июля 2014 г. Къэгъэзэжьын Iофым дэлажьэрэ Дунае Адыгэ хэсэ зэхащагъ. Бэдзэогъу мазэм, 2014 илъэсым, ихэку къэзыгъэзэжьыхэрэм адэIэпыIэрэ дунае Адыгэ хасэ официалнэу мэлажьэу ыублагъ. Хасэм цIэу фашIыгъэр Хэкум гъэзэжьынымкIэ Адыгэ Хасэ. Ар Канада хэгъээгум официалнэу щатхыгъ. Дунае хасэм игупчъэ къалэу Уатерло дэт. Отправить по электронной почте. Написать об этом в блоге. 27 июня 2014 г. ТхьакIущынэ Аслъан кощын Iофхэм ипащэу агъэнэфэгъэм IукIагъ. Написать об этом в блоге.
